Delivery Order SPE2DR25D2001-SPE2DR26FBGM7
- Not listed
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (subsidiary of Cencora, Inc.) on January 20, 2026, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 tablets. This firm fixed-price delivery order, valued at $1,592.74, is scheduled for completion by January 21, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a non-set-aside basis through open competition. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,154.12 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 12, 2026, for the supply of Ambien CR 6.25 mg tablets in quantities of 100. The contract, which carries an ultimate completion date of January 13, 2026, represents a task order under a larger indefinite delivery contract vehicle and involves no set-aside designation. Performance will occur at the vendor's location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 8, 2026, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $3,022.06, represents a non-competitive set-aside award with an ultimate completion date of January 9, 2026. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $1,660.44. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively made. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025....
- The Defense Logistics Agency awarded a delivery order valued at $1,876.57 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on January 15, 2026, with an ultimate completion date of January 16, 2026. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance to be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Ambien CR 6.25 mg tablets (100-count units) under a firm fixed-price contract valued at $2,338.65. The order, which was competitively awarded without set-aside designation, is scheduled for completion by December 3, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count packages) with a ceiling value of $1,013.34. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to a qualified vendor. The order is scheduled for completion by December 5, 2025, with fulfillment occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,649.66 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on January 16, 2026, with an ultimate completion date of January 20, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a direct procurement under the company's larger pharmaceutical supply contract vehicle. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a competitive delivery order valued at $2,441.34 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count packaging) on October 22, 2025, with completion targeted for October 23, 2025. The contract utilizes firm fixed pricing with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,360.04 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and a major distribution hub for...
- SPE2DR25D2001Indefinite Delivery Contract
- SPE2DR25D2001-SPE2DR26FBGM7Delivery Order
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 20, 2026, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $8,314.30. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 21, 2026. This delivery order is executed under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. Amerisourcebergen Drug Corp serves as a critical vendor within the Defense Logistics Agency's medical supply chain, supplying a diverse portfolio of pharmaceutical products and medical commodities to support military and veteran healthcare systems. The parent company, Cencora, Inc. (doing business as Amerisourcebergen), maintains significant contracting relationships with federal agencies including the Department of Veterans Affairs and DLA. The DLA Troop Support Medical is planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning Amerisourcebergen to continue serving government healthcare customers including the Defense Health Agency and U.S. Coast Guard through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 1/19/26 |